---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-009843"
form_type: "8-K"
ticker: "AGIO"
cik: "0001439222"
company_name: "AGIOS PHARMACEUTICALS, INC."
filed_at: "2022-01-14T23:59:59+00:00"
generated_at: "2026-06-27T17:53:33.281559+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Agios sets 2022 annual meeting for June 21; stockholder deadlines announced

## Summary
- 2022 annual meeting to be held virtually on June 21, 2022.
- Deadline for Rule 14a-8 stockholder proposals for proxy inclusion is January 28, 2022.
- Other proposals or director nominations must be submitted between January 20 and February 19, 2022.
- Meeting date is more than 30 days after 2021 annual meeting, triggering adjusted deadline rules.
- Proposals must comply with applicable laws and company bylaws.

## SEC filing metadata
- accession: 0001193125-22-009843
- form_type: 8-K
- ticker: AGIO
- cik: 0001439222
- company_name: AGIOS PHARMACEUTICALS, INC.
- filed_at: 2022-01-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439222/000119312522009843/0001193125-22-009843-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439222/000119312522009843/d295722d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-009843
- JSON: https://secwatch.observer/filing/0001193125-22-009843.json
- Plain text: https://secwatch.observer/filing/0001193125-22-009843.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.